Serine−Threonine Protein Phosphatase Inhibitors: Development of Potential Therapeutic Strategies
- 19 February 2002
- journal article
- review article
- Published by American Chemical Society (ACS) in Journal of Medicinal Chemistry
- Vol. 45 (6), 1151-1175
- https://doi.org/10.1021/jm010066k
Abstract
No abstract availableKeywords
This publication has 97 references indexed in Scilit:
- Protein Phosphatase-1 Activation and Association with the Retinoblastoma Protein in Colcemid-Induced ApoptosisBiochemical and Biophysical Research Communications, 1999
- A Model for Binding of Structurally Diverse Natural Product Inhibitors of Protein Phosphatases PP1 and PP2AJournal of Medicinal Chemistry, 1997
- Localization of the calcium/calmodulin-dependent protein phosphatase, calcineurin, in the hindbrain and spinal cord of the ratJournal of Comparative Neurology, 1996
- Crystal Structure of the Catalytic Subunit of Human Protein Phosphatase 1 and its Complex with TungstateJournal of Molecular Biology, 1995
- Epidermal growth factor-induced protection of tumour cell susceptibility to cytolysisEuropean Journal of Cancer, 1995
- Effects of CGRP in different models of mouse ear inflammationLife Sciences, 1994
- Comparative effects of protein phosphatase inhibitors (okadaic acid and calyculin A) on human leukemia HL60, HL60/ADR and K562 cellsBiochemical and Biophysical Research Communications, 1992
- Calyculin A and okadaic acid: Inhibitors of protein phosphatase activityBiochemical and Biophysical Research Communications, 1989
- In Vitro activity of the novel antitumor antibiotic fostriecin (CI-920) in a human tumor cloning assayEuropean Journal of Cancer and Clinical Oncology, 1986
- Relative reactivities of representative aldehydes and ketones toward trimethylsilyl-substituted propargylic boranesThe Journal of Organic Chemistry, 1985